Recent developments include a new CEO appointment, a significant stock price increase following an AI initiative, strategic partnerships to enhance brand influence, and a Nasdaq notification regarding compliance.

• Meiwu Technology appointed a new CEO in February 2026 to drive growth and strategic initiatives [N2].
• The company’s stock price increased by 123% after introducing a new AI insights initiative in March 2026 [N1].
• Meiwu Technology partnered with Shenzhen Zhinuo Weichuang in mid-2025 to boost brand influence and market competitiveness [N3][N4].
• The company received a Nasdaq notification in March 2025 regarding minimum bid price non-compliance [N5].
• In March 2026, Meiwu Technology closed a $14 million registered direct offering involving ordinary shares and warrants to support working capital and corporate purposes [S2].

The company’s focus on functional skincare products, which generated 100% of revenue in 2025, represents a strategic shift from prior businesses. Strong liquidity ratios and recent capital raises provide financial flexibility. Partnerships with Shenzhen Zhinuo Weichuang and leadership changes, including a new CEO appointment, may support brand growth and operational improvements. The company’s control over product delivery and pricing in offline sales channels supports its principal role and potential for margin management.

Meiwu Technology reported a significant net loss of $18.59 million in 2025 and has material weaknesses in internal controls over financial reporting due to insufficient in-house accounting expertise. Operating expenses increased substantially, driven by reorganization and intangible asset amortization. The company received a Nasdaq notification regarding minimum bid price non-compliance, indicating regulatory challenges. Asset impairment losses increased, reflecting risks in prior business segments. These factors may constrain operational and financial stability.

Meiwu Technology's moat is primarily based on its brand reputation in the functional skincare market and its ability to manage operating expenses amid a competitive environment. The company’s control over inventory and delivery in its offline sales channels supports its principal role in transactions. However, the company faces challenges including material weaknesses in financial reporting controls and significant operating losses, which may impact its competitive positioning. Its partnerships to boost brand influence and recent leadership changes indicate efforts to strengthen its market presence.

• Material Weakness in Internal Controls: The company has identified material weaknesses in its internal control over financial reporting due to lack of in-house accounting personnel with sufficient US GAAP and SEC reporting experience, which may lead to misstatements in financial statements if not remediated.
• Operating Losses and Expense Increases: Significant net losses and increased operating expenses, including amortization of intangible assets and recruitment costs, may impact financial sustainability.
• Regulatory Compliance Risk: The company received a Nasdaq notification regarding minimum bid price non-compliance, posing risks related to continued listing and regulatory adherence.
• Asset Impairment: Increased asset impairment losses related to receivables and intangible assets from prior businesses may affect financial condition.
• Market and Competitive Risks: The company’s business is influenced by economic, political, and social conditions in the PRC and competitive pressures, which may affect demand and profitability.

• Meiwu Technology Co Ltd operates primarily in the functional skincare products business, which generated 100% of its revenue for the year ended December 31, 2025, after ceasing its SMS business in 2024.
• The company sells products both online and offline, with offline sales focusing on functional skincare and health products, acting as principal in these transactions by controlling inventory and delivery.
• Revenue recognition follows ASC 606 principles, recognizing revenue at the point control transfers to customers, with sales returns historically insignificant.
• The company reported a net loss of $18.59 million for the year ended December 31, 2025, with basic and diluted EPS of -$0.82.
• Cash and cash equivalents were $17.88 million as of December 31, 2025, with a current ratio of 15.81 and a cash ratio of 13.65, indicating strong liquidity.
• Operating expenses increased significantly in 2025, driven by reorganization, recruitment, and amortization of intangible assets related to new business in functional skincare products.
• The company experienced an increase in asset impairment losses in 2025, mainly related to receivables and intangible assets from prior businesses.
• Meiwu Technology received a Nasdaq notification regarding minimum bid price non-compliance in March 2025.
• The company appointed a new CEO in February 2026 to drive growth.
• In March 2026, Meiwu Technology closed a $14 million registered direct offering involving ordinary shares and warrants, with proceeds intended for working capital and general corporate purposes.
• The company has material weaknesses in internal control over financial reporting due to lack of in-house accounting personnel with sufficient US GAAP and SEC reporting experience, and is implementing remediation measures including hiring outside financial personnel.
• The board includes audit committee financial experts and has adopted insider trading and compensation recovery policies.
• Meiwu Technology has partnerships and collaborations with Shenzhen Zhinuo Weichuang to enhance brand influence and market competitiveness.
• The company’s business and results are influenced by economic, political, and social conditions in the PRC and competitive environment, with brand reputation and operating expense management being key factors.
• The company’s liquidity is primarily funded by equity contributions from shareholders, with net cash provided by operating activities of approximately $9.0 million in 2025.
• The company’s revenue mix shifted significantly after ceasing SMS business, with functional skincare products becoming the sole revenue source in 2025.
• The company’s revenue contracts are fixed-price with a single performance obligation, and revenue is recognized when control transfers to customers evidenced by signed proof of delivery.